Identification of Immune-Associated Hub Genes Related to the G2/M Checkpoint Pathway in Bladder Cancer Through Integrated Bioinformatics Analysis
Bladder cancer is a highly heterogeneous malignancy characterized by complex immune interactions that influence disease progression and patient outcomes. Identifying immune-related molecular determinants with prognostic and therapeutic relevance is therefore critical. This study aimed to systematically investigate...